Medicare spending analysis for Home Infusion Therapy Services providers
Home Infusion Therapy Services accounts for $9.2M in Medicare payments across 128 providers.
The specialty's average markup of 3.7x is below the overall Medicare average of 3.77x.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2021 | $3.4M | 41.8K | 46 | — |
| 2022 | $3.1M | 79.2K | 43 | -9.7% |
| 2023 | $2.7M | 73.9K | 39 | -10.9% |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| G0068 | Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each inf | $1.1M | 21.7K | $50.32 |
| G0070 | Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes | $683.6K | 5.6K | $121.05 |
| G0069 | Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes | $682.6K | 33.2K | $20.53 |
| J7999 | Compounded drug, not otherwise classified | $157.2K | 6.4K | $24.67 |
| G0089 | Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes | $51.9K | 2.7K | $19.10 |
| G0090 | Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes | $44.0K | 506 | $87.05 |
| J1170 | Injection, hydromorphone, up to 4 mg | $7.6K | 2.4K | $3.13 |
| G0088 | Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biologic | $6.9K | 185 | $37.28 |
| J2270 | Injection, morphine sulfate, up to 10 mg | $3.1K | 1.1K | $2.80 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.